Chris Kaster is listed as a director on 5 SEC Form D filings by 3 issuers between Feb 2011 and May 2025: SONOMA ORTHOPEDIC PRODUCTS INC (Santa Rosa, CA — other health care — 2011; $22.1M reported sold to 20 investors), Farapulse, Inc. (Menlo Park, CA — biotechnology — 2016–2017; $15M reported sold to 35 investors) and Lhotse Medical, Inc. (Dallas, TX — other technology — 2024–2025; $2.19M reported sold to 7 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as director, over about 14 years. Across those companies the filings report $39.3M sold in total.
Listed alongside Allan Zingeler (2 shared filings), Anand Doraiswamy (2 shared filings), Carter Meyer (2 shared filings), James Eadie (2 shared filings), Josh Baltzell (2 shared filings) and 7 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Chris. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 5 public filings for Chris Kaster and found 6 differences: Form D filed 27 days after the first sale; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.